SG
Sangamo Therapeutics, Inc.
SGMOQ · OTC
$0.15 -3.54% (-$0.01)
1M -10.00%
Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
42 /100
Moderate Beta 1.40x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SGMOQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alexander D. Macrae
Employees
142
Headquarters
Richmond
Prihajajoči dogodki
14 SEP.
Earnings
Upcoming earnings report
29 OKT.
Earnings
Upcoming earnings report